Skip to Main Content

Paper Details

Germline genetic variants and pediatric rhabdomyosarcoma outcomes: a report from the Children's Oncology Group.
J Natl Cancer Inst
2
2023
-FOXO1 fusion, CTNNA3 rs2135732, FOXO1, GATA2, GATA3, Germline genetic variants, MED31, PAX3/7, RMS, RNF19A, SNP, SPAG1, alveolar, alveolar RMS, alveolar and embryonal RMS, genetic variants, germline variants, pediatric, pediatric cancers, rhabdomyosarcoma, rs10094840, rs17321084, rs74504320, single nucleotide polymorphism, transcription factors
Author NameAffiliation
Michael E ScheurerBaylor College of Medicine
Michael E ScheurerDan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine
Javed KhanCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Javed KhanCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Stephen J ChanockNational Cancer Institute, National Institutes of Health
Meredith YeagerFrederick National Laboratory for Cancer Research
Meredith YeagerFrederick National Laboratory for Cancer Research
Donald A BarkauskasKeck School of Medicine of the University of Southern California
Donald A Barkauskas
Donald A BarkauskasKeck School of Medicine of the University of Southern California
Donald A Barkauskas
Aniko SaboBaylor College of Medicine
Paul ScheetThe University of Texas MD Anderson Cancer Center
Paul ScheetThe University of Texas MD Anderson Cancer Center
Chad D HuffThe University of Texas MD Anderson Cancer Center
Douglas S HawkinsSeattle Children's Hospital, University of Washington
Lisa MirabelloClinical Genetics Branch, National Cancer Institute, National Institutes of Health
Lisa MirabelloClinical Genetics Branch, National Cancer Institute, National Institutes of Health
  • 1 - 19

Datasets

Release 1.2